This is a preprint.
New Dual Inducible Cellular Model to Investigate Temporal Control of Oncogenic Cooperating Genes
- PMID: 38464002
- PMCID: PMC10925205
- DOI: 10.1101/2024.02.23.581802
New Dual Inducible Cellular Model to Investigate Temporal Control of Oncogenic Cooperating Genes
Update in
-
New dual inducible cellular model to investigate temporal control of oncogenic cooperating genes.Sci Rep. 2024 Sep 5;14(1):20773. doi: 10.1038/s41598-024-71227-3. Sci Rep. 2024. PMID: 39237585 Free PMC article.
Abstract
The study of cooperating genes in cancer can lead to mechanistic understanding and identifying potential therapeutic targets. To facilitate these types of studies, we developed a new dual-inducible system utilizing the tetracycline- and cumate-inducible systems driving HES3 and the PAX3::FOXO1 fusion-oncogene, respectively, as cooperating genes from fusion-positive rhabdomyosarcoma. With this new model, we can independently induce expression of either HES3 or PAX3::FOXO1, as well as simultaneously induce expression of both genes. This new model will allow us to further investigate the cooperation between HES3 and PAX3::FOXO1 including the temporal requirements for genetic cooperation. This dual-inducible model can be adapted for any cooperating genes, allowing for independent, simultaneous, or temporally controlled gene expression.
Similar articles
-
New dual inducible cellular model to investigate temporal control of oncogenic cooperating genes.Sci Rep. 2024 Sep 5;14(1):20773. doi: 10.1038/s41598-024-71227-3. Sci Rep. 2024. PMID: 39237585 Free PMC article.
-
PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis.Elife. 2018 Jun 5;7:e33800. doi: 10.7554/eLife.33800. Elife. 2018. PMID: 29869612 Free PMC article.
-
IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS).Carcinogenesis. 2011 Apr;32(4):452-61. doi: 10.1093/carcin/bgq273. Epub 2010 Dec 22. Carcinogenesis. 2011. PMID: 21177767 Free PMC article.
-
PAX3-FOXO1: Zooming in on an "undruggable" target.Semin Cancer Biol. 2018 Jun;50:115-123. doi: 10.1016/j.semcancer.2017.11.006. Epub 2017 Nov 14. Semin Cancer Biol. 2018. PMID: 29146205 Review.
-
Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma.Molecules. 2018 Oct 28;23(11):2798. doi: 10.3390/molecules23112798. Molecules. 2018. PMID: 30373318 Free PMC article. Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous